ISCNF   $0.023  1.32% Market Closed

Isracann Biosciences Inc
Total Cash 198.05K
totalCashPerShare 0.001
EBITDA -2.19M
Total Debt 0.00
quickRatio 0.273
currentRatio 0.295
Total Revenue
debtToEquity
Revenue/Share
ROA -0.34993
ROE -2.52753
grossProfits
freeCashflow -567.05K
operatingCashflow -1.48M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -201.17K
forwardPE
floatShares 175.79M
sharesOutstanding 175.99M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.00%
heldPercentInstitutions 0.0
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue 0.001
Price To Book help_outline 0.10
earningsQuarterlyGrowth
netIncomeToCommon -4.54M
trailingEps -0.02%
forwardEps
enterpriseToEbitda 0.09
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 0
lastUpdated Nov. 7, 2024, 3:05 a.m.